Despite initially favorable prognosis in patients with non-Q-wave acute myocardlal infarction (AMI), long-term mortality In thls subset of patients appears to be similar to or even greater than that In patients wlth Q-wave AMI. The relatively poor late prognosis is primarily due to a hlgh lncldence of unstable angina and recurrent AMI. Between January 1982 and January 1987, 114 patients with suitable coronary narrowing underwent percutaneous translumlnal coronary angkplasty (PTCA) for angina pectoris (present elther at rest or during mlld exertion, and despite optimal pharmacologic therapy), a median of 31 (range 2 to 382) days after a non-Q-wave AMI. 
T he clinical course of patients with non-Q-wave acute myocardial infarction (AMI) has been a subject of interest. Natural history studies have suggested that, compared with Q-wave AMI, non-Q-wave AM1 is associated with less necrosis, better left ventricular function and lower in-hospital mortality. Despite this more favorable initial prognosis, long-term survival for patients with non-Q-wave AM1 appears to be similar to or even less than that in patients with Q-wave AMI.l-13
The relatively high mortality rate of patients with non-Q-wave AM1 seems to be related to unstable angina or subsequent recurrent AM1 in the same area'-'0 and may be preventable if recurrent AM1 can be averted with revascularization. The present study describes the short-and longterm results of consecutive patients treated with per-cutaneous transluminal coronary angioplasty (PTCA) for severe angina after a non-Q-wave AMI.
Methods

Patients:
The study population consisted of 114 patients with a non-Q-wave AM1 who underwent PTCA between January 1982 and January 1987. All had symptoms of angina, either at rest or during mild exertion, despite optimal pharmacologic therapy. They represented 8% of our total PTCA population during the study period. Non-Q-wave AM1 was defined in this study as prolonged chest pain compatible with AMI, associated with electrocardiographic ST-segment and T-wave abnormalities without progression to pathologic Q waves, but with abnormal elevation of the creatinine kinase level (at least twice of the normal value) before any intervention. Postinfarction angina was considered unstable if it occurred at rest lasting for at least 15 minutes and was associated with electrocardiographic manifestations of myocardial ischemia without evidence of further myocardial necrosis.
Patients were selected for PTCA if the ischemiarelated lesion was suitable for dilatation. The selection was based only on symptoms and coronary anatomy, and was not influenced by left ventricular function. PTCA was considered successful when a reduction of the severity of the obstruction to <50% luminal diameter narrowing was achieved with abolition of acute ischemic symptoms and without progression to AMI, emergency surgery or death. PTCA was performed a median of 31 (range 2 to 362) days after non-Q-wave AMI; 53% of the procedures were performed within 30 days of AMI. Clinical and angiographic data are summarized in Table I . After the procedurei patients were monitored for 24 hours in the medium care unit. They were treated with nifedipine 60 mg daily and acetylsalicylic acid 500 mg daily over a period of 6 months.
All patients were followed at the outpatient clinic. Survival status, recurrent AMI, angina pectoris, cardi- 
Results
From the 114 patients who underwent PTCA for angina after a non-Q-wave AMI, 129 lesions were dilated. Single-vessel dilatation was performed in 100 patients, including 16 multilesion dilatations in the same artery. Double artery dilatation was performed in 13 patients and triple artery dilatation in 1 (Table II) . Success was achieved in dilating the obstructed artery in 98 patients (113 lesions). Figure 1 shows the clinical outcome of all patients. In 16 patients, the attempted PTCA was unsuccessful: in 9 because the artery was occluded, in 5 because the stenosis could not be crossed with either the guidewire or balloon catheter and in 2 because of abrupt closure or major dissection, Peri-interventional AMI, defined by either cardiac enzyme elevation or new Q waves, Abbreviations as in Table I. was documented in 5 patients, of whom 3 underwent emergency bypass Surgery. Of the 98 successfully treated patients, 62 were asymptomatic and 5 developed a nonfatal recurrent AM1 (1 of them underwent an urgent PTCA). Thirtyone patients develoIjed recurrent angina and of these, 5 underwent an elective bypass surge@ 168 (range 7 to 534) days after the initial procedure, 8 were controlled by pharmacologic therapy, and 18 underwent a repeat PTCA 120 [range 1 to 300) days after the initial pro&-dure. Success was achieved in redilating the artery in 16 patients.
Results of electrocardiographic exercise testing were available in 71% (70 of 981 of the patients, 8 (range 1 to 49) months after initially successful PTCA (Figure 2 ). The mean maximum workload achieved, predicted for age, sex and height, was 98% (range 54 to A maximum workload of >80'% and >lOCi% predlcted for &e, sex and height was achlived In 89% and 52% of'the patlents; respectlvely. The majority of the patlents (92%) were symptom-free durIng the test; an lschemlc ST-segment depresslon was documented In 27%. Abbreviations as in Table I. summarized in Table III . If coronary artery bypass surgery, recurrent AMI, death or recurrent angina requiring pharmacologic therapy were to be considered events, 74% of the patients wodld be considered event-free at 20 months after successful PTCA, whereas if any cardiac recurrence, including repeat PTCA, were to be considered events, only 63% of patients would be event-free at 20 months ( Figure 3 ).
Discussion
The reported ificidence of non-Q-wave AMI varies between 20 and 36% of all AMIs.~,~~~J~ Although non-Q-wave AM1 and Q-wave AM1 (as classified by electrocardiographic results] cannot always be anatomically differentiated ,4J4 it seems likely that they differ clinically, physiologically and prognostically, as discussed by Spodick.15 Despite the initially limited area of myocarditil necrosis and favorable short-term p~og-nosis for patients with non;Q-wave AMI, several studies show substantial late morbidity and mortality rates in these patientsI-l3 Despite marked improvement in late CABG FIGURE 3. lf coronary artery bypass surgery (CABG), recurrent myocardlal lnfarctlbn (re-MI), death or recurrent anglna requiring pharmacologic therapy (Rx Med) were to be considered events, 74% of the patlents would be consldered ivent-free (Asympt.) at 20 monihs after lnltlally successful angloplasty, whereas If any cardiac recurrence, kicludlng repeat coronary angloplasty (Re-PTCA) were to be considered an event, only 83% of patients would be event-free. pharmacologic therapy, the reported incidence of recurrent AMIs remains high at 6 to 86% and is associated with a poor prognosis. 1,4-6.10,16,17 Ma+1 et a15 rem ported a high mortality, both early and late, for patients with subsequent extension following a non-Q-wave AMI. In-hospital mortality rate in this subset of patients was 43%, while in those with Q-wave AM1 was 15%. The l-year cumulative survival rates for patients with Q-versus non-Q-wave AM1 without extension were similar: 82% and 84%. For those with extension, however, l-year survival rates were 66% and 3570, respectively. This finding was supported by otheps. 1, 3, 10, 18, 19 Several investigators suggest that coronary bypass surgery or PTCA is feasible and safe for patients with angina after non-Q-wave AMI.20-23 Our present results indicate not only that PTCA can be performed safely and effectively in this subset of patients, but also that the incidences of late recurrent AM1 (6%) and cardiac death (070) are lower than expected. However, recurrent angina occurred in 32% of our patients after successful PTCA, a percentage similar to that reported for stable angina. 24 All patients were satisfactorily treated by repeat PTCA, coronary bypass surgery or pharmacologic therapy. These findings are comparable with the general results of the total PTCA population during the same period, perhaps because PTCA was performed in half of the patients >l month after non-Q-wave AMI, thus hindering any significant distinction between them and an average PTCA population. However, the time delay from non-Q-wave AM1 to PTCA did not affect the outcome, despite the fact that unstable angina was more frequent among the patients treated within 30 days than those treated >30 days, as shown in Table IV .
Among the 22 patients with a totally occluded artery at the time of PTCA, attempted recanalization was successful in only 13 (success rate of 59%), and of these, repeat PTCA or coronary bypass surgery or both was necessary in 6. Of the 9 unsuccessful cases, 3 underwent emergency bypass surgery, 5 had residual angina controlled by pharmacologic therapy and 1 was asymptomatic. When these patients with a totally occluded artery were excluded, the primary success rate became 92%. These findings suggest that when the artery is occluded, the benefits of PTCA after a non-Qwave AM1 are limited, even when recanalization is initially successful.
Limitations of this study include the fact that it was uncontrolled and involved only patients with non-Qwave AM1 with recurrent angina1 symptoms and anatomy suitable for PTCA. In fact, most patients had a single-vessel disease with relatively small to moderate enzymatic infarct size and might be expected to have a favorable outcome. However, these patients constituted a high-risk subgroup because of the presence of ongoing angina, which implied that the cardiac event was not yet complete and suggested that more aggressive invasive management could have improved clinical status and the condition of the myocardium.
The high initial success rate and the low incidence of subsequent death and late recurrent AMI, as well as the sustained beneficial effect, suggest that PTCA is an effective initial treatment strategy in patients with angina after a non-Q-wave AMI.
